rs118204045

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3PP5

The NM_015702.3(MMADHC):​c.545C>A​(p.Thr182Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,456,816 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

MMADHC
NM_015702.3 missense

Scores

4
14

Clinical Significance

Pathogenic no assertion criteria provided P:1

Conservation

PhyloP100: 9.14

Publications

4 publications found
Variant links:
Genes affected
MMADHC (HGNC:25221): (metabolism of cobalamin associated D) This gene encodes a mitochondrial protein that is involved in an early step of vitamin B12 metabolism. Vitamin B12 (cobalamin) is essential for normal development and survival in humans. Mutations in this gene cause methylmalonic aciduria and homocystinuria type cblD (MMADHC), a disorder of cobalamin metabolism that is characterized by decreased levels of the coenzymes adenosylcobalamin and methylcobalamin. Pseudogenes have been identified on chromosomes 11 and X.[provided by RefSeq, Nov 2008]
MMADHC Gene-Disease associations (from GenCC):
  • inborn disorder of cobalamin metabolism and transport
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • methylmalonic aciduria and homocystinuria type cblD
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.84
PP5
Variant 2-149575775-G-T is Pathogenic according to our data. Variant chr2-149575775-G-T is described in ClinVar as Pathogenic. ClinVar VariationId is 762.Status of the report is no_assertion_criteria_provided, 0 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_015702.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MMADHC
NM_015702.3
MANE Select
c.545C>Ap.Thr182Asn
missense
Exon 6 of 8NP_056517.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MMADHC
ENST00000303319.10
TSL:1 MANE Select
c.545C>Ap.Thr182Asn
missense
Exon 6 of 8ENSP00000301920.5
MMADHC
ENST00000422782.2
TSL:5
c.545C>Ap.Thr182Asn
missense
Exon 6 of 9ENSP00000408331.2
MMADHC
ENST00000428879.5
TSL:2
c.545C>Ap.Thr182Asn
missense
Exon 5 of 7ENSP00000389060.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1456816
Hom.:
0
Cov.:
29
AF XY:
0.00000276
AC XY:
2
AN XY:
724916
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33350
American (AMR)
AF:
0.00
AC:
0
AN:
44560
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26012
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39452
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85786
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53294
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5714
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1108424
Other (OTH)
AF:
0.00
AC:
0
AN:
60224
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Homocystinuria-megaloblastic anemia cblD type Pathogenic:1
Apr 03, 2008
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.93
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Uncertain
-0.030
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.73
D
Eigen
Uncertain
0.53
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.89
D
M_CAP
Uncertain
0.14
D
MetaRNN
Pathogenic
0.84
D
MetaSVM
Uncertain
0.73
D
MutationAssessor
Uncertain
2.5
M
PhyloP100
9.1
PrimateAI
Uncertain
0.74
T
PROVEAN
Uncertain
-2.9
D
REVEL
Pathogenic
0.70
Sift
Uncertain
0.019
D
Sift4G
Uncertain
0.025
D
Polyphen
0.82
P
Vest4
0.96
MutPred
0.52
Loss of phosphorylation at T182 (P = 0.0187)
MVP
0.85
MPC
0.052
ClinPred
0.99
D
GERP RS
4.5
Varity_R
0.82
gMVP
0.71
Mutation Taster
=1/99
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs118204045; hg19: chr2-150432289; API